Cancer
Malignant Pancreatic Neoplasm
CI-CAN-00001159Explore in graph →
Top-level904 active trials8 approved drugs63 evidence items
- NCIt
- C9005
- ICD-10
- C25
- DOID
- 1793
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001159Explore in graph →
Clinical trials
3,630 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (516)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00964171 | Efavirenz as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer(PANTER) | completed | Phase 2 | 19 | Institut BergoniéOTHER | 1 | Aug 28, 2025 | clinicaltrials |
| NCT05044065 | Blood Flow Restriction Exercise in Patients With Pancreatic, Biliary Tract, and Liver Cancer (PREV-Ex)(PREV-Ex) | completed | N/A | 52 | Karolinska InstitutetOTHER | 2 | Aug 27, 2025 |
| clinicaltrials |
| NCT06582849 | Enhanced Assistance During Radiotherapy for Unmet Essential Needs(EARN) | completed | N/A | 33 | Washington University School of MedicineOTHER | 1 | Aug 26, 2025 | clinicaltrials |
| NCT04191421 | Siltuximab and Spartalizumab in Patients With Metastatic Pancreatic Cancer | completed | Phase 1 / Phase 2 | 35 | Emory UniversityOTHER | 1 | Aug 22, 2025 | clinicaltrials |
| NCT05259696 | Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)(GLIMMER-01) | completed | Phase 1 / Phase 2 | 69 | Palleon Pharmaceuticals, Inc.INDUSTRY | 1 | Aug 20, 2025 | clinicaltrials |
| NCT04409002 | Niraparib + Dostarlimab + RT in Pancreatic Cancer | completed | Phase 2 | 18 | Massachusetts General HospitalOTHER | 1 | Aug 15, 2025 | clinicaltrials |
| NCT04825834 | DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)(DELFI-L101) | completed | — | 2,992 | Delfi Diagnostics Inc.INDUSTRY | 2 | Aug 8, 2025 | clinicaltrials |
| NCT03697564 | Nivolumab + Cabiralizumab + Gemcitabine in Patients With Stage IV Pancreatic Cancer | completed | Phase 2 | 2 | Hitendra PatelOTHER | 1 | Aug 6, 2025 | clinicaltrials |
| NCT04634539 | Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer | completed | Phase 1 | 18 | Jun Gong, MDOTHER | 1 | Aug 6, 2025 | clinicaltrials |
| NCT06048367 | Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor(CNSI-Fe(II)) | completed | Phase 1 | 19 | Sichuan Enray Pharmaceutical Sciences CompanyOTHER | 1 | Aug 3, 2025 | clinicaltrials |
| NCT05430841 | Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CT | completed | N/A | 120 | The First Affiliated Hospital of Xiamen UniversityOTHER | 1 | Aug 1, 2025 | clinicaltrials |
| NCT03033225 | Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study | completed | Phase 2 | 13 | Mayo ClinicOTHER | 1 | Jul 30, 2025 | clinicaltrials |
| NCT03434678 | Use of Epidurals Intraoperatively for Patients Undergoing Pancreas Resection | completed | Phase 3 | 133 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 30, 2025 | clinicaltrials |
| NCT05292859 | Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs | completed | — | 7 | Alaunos TherapeuticsINDUSTRY | 1 | Jul 30, 2025 | clinicaltrials |
| NCT07091097 | Multivisceral Oncological Resections Involving the Pancreas - An International Multicenter Study(MORIP-AIMS) | completed | — | 1,283 | Martin-Luther-Universität Halle-WittenbergOTHER | 1 | Jul 29, 2025 | clinicaltrials |
| NCT02030860 | A Study of Neoadjuvant Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer | completed | Phase 1 | 15 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jul 25, 2025 | clinicaltrials |
| NCT01781728 | Palliative Stereotactic Radiation for Pancreatic or Periampullary Adenocarcinoma | completed | Phase 2 | 48 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jul 20, 2025 | clinicaltrials |
| NCT03199586 | Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies | completed | Phase 1 | 23 | Novita Pharmaceuticals, Inc.INDUSTRY | 1 | Jul 20, 2025 | clinicaltrials |
| NCT01342354 | Study of Stereotactic Body Radiation Therapy in Patients With Intact Pancreatic Cancer | completed | Phase 1 / Phase 2 | 15 | University of ChicagoOTHER | 1 | Jul 18, 2025 | clinicaltrials |
| NCT04923529 | TAS-102 in Patients With Advanced, Refractory Pancreatic Adenocarcinoma | completed | Phase 2 | 28 | The University of Hong KongOTHER | 1 | Jul 18, 2025 | clinicaltrials |
| NCT05078775 | Medical Food for the Dietary Management of Advanced/Metastatic Pancreatic Cancer | completed | N/A | 39 | Faeth TherapeuticsINDUSTRY | 1 | Jul 18, 2025 | clinicaltrials |
| NCT07072897 | A Study Comparing Restrictive and Liberal Fluid Therapy During Pancreatecoduodenectomy Surgery | completed | N/A | 44 | Tribhuvan University Teaching Hospital, Institute Of Medicine.OTHER | 1 | Jul 18, 2025 | clinicaltrials |
| NCT04580485 | INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors | completed | Phase 1 | 54 | Incyte CorporationINDUSTRY | 6 | Jul 11, 2025 | clinicaltrials |
| NCT07057843 | Sequential Nutrition Intervention for Pancreatic Cancer Patients Undergoing CyberKnife Radiotherapy | completed | N/A | 100 | The First Hospital of Hebei Medical UniversityOTHER | 1 | Jul 10, 2025 | clinicaltrials |
| NCT02611024 | Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors | completed | Phase 1 / Phase 2 | 316 | PharmaMarINDUSTRY | 6 | Jul 9, 2025 | clinicaltrials |
| NCT06481397 | OSCAR I STUDY - The ONCObind CTC Removal Study | completed | N/A | 5 | ExThera Medical CorporationINDUSTRY | 1 | Jul 2, 2025 | clinicaltrials |
| NCT02723331 | Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates | completed | Phase 2 | 48 | Academic Thoracic Oncology Medical Investigators ConsortiumINDUSTRY | 1 | Jul 1, 2025 | clinicaltrials |
| NCT03693677 | First Line Metastatic Pancreatic Cancer : 5FU/LV+Nal-IRI, Gemcitabine+Nab-paclitaxel or a Sequential Regimen of 2 Months 5FU/LV+Nal-IRI(FUNGEMAX) | completed | Phase 2 | 288 | Federation Francophone de Cancerologie DigestiveOTHER | 2 | Jul 1, 2025 | clinicaltrials |
| NCT02159716 | CART-meso in Mesothelin Expressing Cancers | completed | Phase 1 | 19 | University of PennsylvaniaOTHER | 1 | Jun 29, 2025 | clinicaltrials |
| NCT03592888 | DC Vaccine in Pancreatic Cancer | completed | Phase 1 | 29 | University of PennsylvaniaOTHER | 1 | Jun 29, 2025 | clinicaltrials |
| NCT02078700 | Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study. | completed | Phase 2 | 40 | Azienda USL Reggio Emilia - IRCCSOTHER_GOV | 1 | Jun 25, 2025 | clinicaltrials |
| NCT03267524 | Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal Cancer and Their Family Caregivers | completed | N/A | 87 | City of Hope Medical CenterOTHER | 1 | Jun 22, 2025 | clinicaltrials |
| NCT04422730 | Evolution of Body Connection After Surgery | completed | — | 129 | Institut Paoli-CalmettesOTHER | 1 | Jun 18, 2025 | clinicaltrials |
| NCT04984174 | Survival Rate and Treatment Cost in Patients With Pancreatic Cancer: An Analysis Using NHIS Database and K-PaC Registry Focusing on Liposomal Irinotecan | completed | — | 14,760 | National Cancer Center, KoreaOTHER_GOV | 1 | Jun 18, 2025 | clinicaltrials |
| NCT05788484 | A Study of CDX-585 in Patients With Advanced Malignancies | completed | Phase 1 | 20 | Celldex TherapeuticsINDUSTRY | 1 | Jun 15, 2025 | clinicaltrials |
| NCT01351103 | A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands | completed | Phase 1 | 185 | Novartis PharmaceuticalsINDUSTRY | 7 | Jun 13, 2025 | clinicaltrials |
| NCT03510754 | Endoscopic Ultrasound-guided Biliary Drainage for Malignant Biliary Obstruction After Failed ERCP((EUS-BD)) | completed | — | 36 | Azienda USL Reggio Emilia - IRCCSOTHER_GOV | 0 | Jun 11, 2025 | clinicaltrials |
| NCT03572283 | Bethanechol Prior to Pancreatic Surgery | completed | Early Phase 1 | 17 | Columbia UniversityOTHER | 1 | Jun 5, 2025 | clinicaltrials |
| NCT05440942 | Combined MEK, STAT3 and PD-1 Inhibition in Metastatic Pancreatic Ductal Adenocarcinoma | completed | Phase 1 | 28 | Peter Hosein, MDOTHER | 1 | Jun 5, 2025 | clinicaltrials |
| NCT05583890 | A Case-control Study Comparing Glycaemic Control in Pancreatic Cancer Patients vs Healthy Matched Individuals.(PanCanCGM) | completed | — | 29 | Lancaster UniversityOTHER | 1 | Jun 4, 2025 | clinicaltrials |
| NCT04834505 | To Differentiate Focal Autoimmune Pancreatitis From Pancreatic Cancer by Endoscopic Ultrasound | completed | — | 286 | Peking Union Medical College HospitalOTHER | 1 | May 31, 2025 | clinicaltrials |
| NCT04068896 | Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy | completed | Phase 1 / Phase 2 | 89 | NGM Biopharmaceuticals, IncINDUSTRY | 1 | May 29, 2025 | clinicaltrials |
| NCT03250273 | A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma | completed | Phase 2 | 44 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | May 28, 2025 | clinicaltrials |
| NCT06208124 | A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors | completed | Phase 1 / Phase 2 | 30 | Immuneering CorporationINDUSTRY | 1 | May 28, 2025 | clinicaltrials |
| NCT06980792 | Surgical Approach for Adenocarcinoma of the Pancreas With Synchronous Liver Metastases | completed | — | 90 | Azienda Ospedaliero-Universitaria di ModenaOTHER | 1 | May 20, 2025 | clinicaltrials |
| NCT00806611 | Intraoperative Celiac Plexus Neurolysis for Patients With Operable Pancreatic and Periampullary Cancer | completed | Phase 3 | 438 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | May 15, 2025 | clinicaltrials |
| NCT04449679 | Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study | completed | N/A | 34 | Thomas Jefferson UniversityOTHER | 1 | May 15, 2025 | clinicaltrials |
| NCT06967233 | Multimodal Managements for Metastatic Pancreatic Cancer. | completed | — | 360 | Zhejiang UniversityOTHER | 1 | May 13, 2025 | clinicaltrials |
| NCT06241352 | Statin Addition to Chemotherapy for Advanced Pancreatic Cancer | completed | Phase 2 | 42 | Changhai HospitalOTHER | 1 | May 11, 2025 | clinicaltrials |
| NCT04306874 | Whipple Protein Study(WPS) | completed | N/A | 22 | Thomas Jefferson UniversityOTHER | 1 | May 7, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Aug 28, 2025source: clinicaltrials